Clin2
NCT02844764Possibly a fitRecruiting

Cell therapy test for hip osteoarthritis pain and swelling

Osteoarthritis

Treatments studied

Part of Bones, joints & muscles clinical trials.

This trial tests an “autologous” regenerative cell treatment, meaning cells taken from you, to reduce hip osteoarthritis pain and inflammation. It checks safety first and looks for improvements in how you feel and move.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
4,000 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You have hip osteoarthritis (from wear over time or an old injury).
  • You’re between 18 and 90 years old.
  • Your kidney, heart, and lung function are good enough for the study tests.
  • Your blood clotting tests are within the allowed range (PT/INR under 1.5, APTT acceptable).
  • You don’t have immune system problems that you know of, like immunodeficiency.
  • Your hip pain on the affected side has lasted more than 6 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02844738Recruiting· Phase 2
Cell therapy for shoulder osteoarthritis pain and inflammation

This trial tests a treatment using your own (autologous) regenerative cells to reduce pain and inflammation from shoulder osteoarthritis. It may help people with long-lasting shoulder pain, but you must meet several health and medication timing requirements.

Grove City, Pennsylvania
NCT02844751Recruiting· Phase 2
Regenerative knee cell therapy for arthritis pain and swelling

This Phase 2 study tests a patient’s own (autologous) regenerative cell treatment to reduce knee pain and inflammation from osteoarthritis. It mainly looks at whether the treatment is safe and whether it can improve symptoms over time.

Grove City, Pennsylvania
NCT03984461Recruiting· Phase 2
Platelet-rich treatment with joint fluid or bone cells for arthritis

This trial tests a joint treatment made from your own platelets (platelet-rich plasma, or PRP) combined with other biologic material (from fat tissue and/or bone marrow) to help osteoarthritis symptoms. It may be an option if you have early-to-moderate osteoarthritis in a major joint and meet safety requirements.

Kelowna, British Columbia
NCT04238143Recruiting
Knee and other joint arthritis tissue therapy

This trial tests a regenerative therapy made from a patient’s own fat tissue (a “cellular” treatment) to reduce pain and improve function in arthritis-related problems. It may help people with inflammatory or degenerative arthritis changes, if they meet safety and tissue-donation requirements.

Valencia, California
NCT05507099Recruiting· Phase 2
Stem cell injections for knee or hip osteoarthritis pain

This Phase 2 study tests whether stem cell injections can reduce pain and improve symptoms in people with knee or hip osteoarthritis. You may be considered if you have moderate-to-severe pain despite trying standard treatments.

Brampton, Ontario
NCT06893250Enrolling by invitation· Phase 2/Phase 3
Orthobiologic treatment for knee osteoarthritis

This study tests a treatment made from your own body's healing components to reduce knee pain. It may help people with mild to moderate knee osteoarthritis who haven't had knee surgery or strong pain relievers lately.

Tromsø, Tromsø

Hear when a new Osteoarthritis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.